Stock Price
28.95
Daily Change
0.06 0.21%
Monthly
-1.66%
Yearly
15.43%
Q4 Forecast
28.24

EPS Reference Time Actual Consensus Previous
2026-11-03 FY2026Q3 AM 0.87 0.84 0.87
2026-08-04 FY2026Q2 AM 0.77 0.68 0.78
2026-05-05 FY2026Q1 AM 0.75 0.73 0.92
2026-02-03 FY2025Q4 AM 0.66 0.6 0.63
2025-11-04 FY2025Q3 AM 0.87 0.71 1.06



Peers Price Chg Day Year Date
AbbVie 296.44 1.41 0.48% 26.68% Nov/16
Abbott 108.53 0.01 0.01% -16.53% Nov/16
ALKERMES 47.34 0.31 0.66% 63.02% Nov/16
Amgen 467.82 2.15 0.46% 36.91% Nov/16
AstraZeneca 14,068.00 86.00 0.62% 3.50% Nov/16
Bayer 57.04 0.52 0.92% 104.12% Nov/16
Biogen 254.36 0.96 0.38% 51.81% Nov/16
Bristol-Myers Squibb 63.31 -0.12 -0.19% 35.25% Nov/16
Coherus Biosciences 0.51 -0.02 -2.97% -57.15% Nov/16
Gilead Sciences 169.38 1.30 0.77% 36.50% Nov/16

Indexes Price Day Year Date
US Index 500 7443 -118.59 -1.57% 11.55% Nov/16

Pfizer traded at $28.91 this Monday November 16th, increasing $0.02 or 0.07 percent since the previous trading session. Looking back, over the last four weeks, Pfizer gained 1.03 percent. Over the last 12 months, its price rose by 15.36 percent. Looking ahead, we forecast Pfizer to be priced at 28.24 by the end of this quarter and at 26.38 in one year, according to Trading Economics global macro models projections and analysts expectations.

Pfizer Inc. (Pfizer) is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products. Its global portfolio includes medicines and vaccines. The Company works across markets to develop wellness, prevention, treatments and cures. It collaborates with healthcare providers, governments and local communities to support and provide access to healthcare. Its medicines and vaccines provide value for healthcare providers and patients, through treatment of diseases, improvements in health, wellness. It sells its prescription pharmaceutical products to wholesalers, retailers, hospitals, clinics, government agencies and pharmacies. In the United States, it sells its vaccines products to the federal government, centers for disease control and prevention (CDC), wholesalers, individual provider offices, retail pharmacies and integrated delivery networks.



News Stream
Pfizer Shares Hit 26-month High
Pfizer shares increased to 30.45 USD, the highest since August 2024. Over the past 4 weeks, Pfizer gained 6.63%, and in the last 12 months, it increased 25.2%.
2026-10-30
Pfizer Shares Hit 23-month High
Pfizer shares increased to 29.22 USD, the highest since October 2024. Over the past 4 weeks, Pfizer gained 5.23%, and in the last 12 months, it increased 18.96%.
2026-10-14
Pfizer Shares Hit 5-week High
Pfizer shares increased to 28.95 USD, the highest since September 2026. Over the past 4 weeks, Pfizer gained 4.26%, and in the last 12 months, it increased 17.86%.
2026-10-14